Thomas N Bryce, MD
- PROFESSOR | Rehabilitation and Human Performance
- ASSOCIATE PROFESSOR | Neurosurgery
Specialties:
Rehabilitation and Physical Medicine, Spinal Cord Injury Medicine
Dr. Thomas Bryce came to The Mount Sinai Medical Center in 1997 and has served as Medical Director of the Spinal Cord Injury Program since 2001 and as Medical Director of Rehabilitation Ambulatory Services since 2008.
He received his undergraduate degree from Johns Hopkins University and his medical degree from Albany Medical College. He received specialty training in Rehabilitation Medicine at Thomas Jefferson University Hospital.
Dr. Bryce is board certified in Physical Medicine and Rehabilitation and has sub-specialty certification in both Pain Medicine and Spinal Cord Injury Medicine.
Dr. Bryce is involved with research related to spinal cord injury especially as it relates to the assessment of pain and neurological function after spinal injury as well as the use of robotic exoskeletons to facilitate walking after spinal cord injury. He is the principle investigator of several ongoing studies in these areas. He has authored numerous chapters and scientific articles on spinal cord injury.
Dr. Bryce has been appointed by Governor Cuomo to the New York State Spinal Cord Research Board.
Dr. Bryce is the Steering Committee Chair of the Consortium for Spinal Cord Medicine, a consortium of national organizations which publishes clinical guidelines related to the care of individuals with spinal cord injury. He is on the Board of the International Spinal Cord Society (ISCoS) and is the Chair of the Communications Committee of ISCoS. He is also a member of the Education Committee of the American Spinal Injury Association (ASIA). He has been a research grant reviewer for the Department of Defense, the European Science Foundation, and the Craig H. Neilsen Foundation.
Dr. Bryce works closely with physical therapists, occupational therapists, neuropsychologists, and other medical and surgical specialists in order to provide comprehensive care.
Dr. Bryce performs all aspects of spasticity management especially as related to intrathecal therapy screening and management from intrathecal test trials to refills and dose adjustments.
Clinical Focus
- Cauda Equina Syndrome
- Intrathecal baclofen pumps
- Multiple Sclerosis
- Myelopathy
- Paraplegia
- Quadriplegia And Paraplegia
- Spasticity
- Spina Bifida
- Spinal Cord Injury
- Tetraplegia
Education
MD, Albany Medical College
Internship, Internal Medicine, Albany Medical Center
Residency, Physical Medicine & Rehabilitation, Thomas Jefferson University Hospital
Dr. Bryce has been involved in several international taskforces related to outcome measures for pain after spinal cord injury, the International Dataset Project, and the classification of pain after spinal cord injury. The last of which he chaired.
At Mount Sinai, Dr. Bryce has been either the principal investigator or site principal investigator for the following funded studies:
A multi-center phase 2 trial eval-uating the efficacy and safety of our neural stem cells (HuCNS-SC) in patients with chronic cervical spinal cord injury
Evoked neuropathic pain in spinal cord injury
A phase II, multiple dose, double blinded, placebo controlled study of HP184 in chronic spinal cord injury patients
A multiple dose, double blinded, placebo controlled safety, tolerability and pharmacokinetic/ pharmacodynamic study of HP184 in chronic spinal cord injury patients
A multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the safety and efficacy of repeat treatment with two dose levels of BOTOX (r) (Botulinum Toxin Type A) purified neurotoxin complex followed by a treatment with BOTOX(r) in patients with urinary incontinence due to neurogenic detrusor overactivity
For a description of ongoing research projects go to this link:
http://labs.icahn.mssm.edu/brycelab/
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Bryce did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.